innovativemedicines.ca Open in urlscan Pro
162.159.134.42  Public Scan

Form analysis
2 forms found in the DOM

/

<form id="search-form" action="/">
  <div class="field">
    <i class="far fa-search"></i>
    <input type="text" name="s" id="header-search-input" placeholder="Search by keyword" value="">
  </div>
  <a id="search-close" aria-label="Close" title="Close"><i class="far fa-times"></i></a>
</form>

/

<form id="search-form-mobile" action="/">
  <div class="field">
    <input type="text" name="s" id="header-search-input" placeholder="Input keyword" value="">
    <i class="far fa-search"></i>
  </div>
</form>

Text Content

Skip to content
 * 
 * 
 * 
 * 

 * Browse by
   * Topic
     * Private Drug Coverage
     * Health Research Foundation
     * Access to Medicine
     * Patented Medicine Prices Review Board (PMPRB)
     * Pharmacare
     * Drugs for Rare Diseases (DRD)

 * Member Login

 *  * Français

 * 


 * Advocacy
   
   ADVOCACY
   
   IMC is committed to working with governments and stakeholders to strengthen
   Canada’s health systems.
   
   Read more
   
    * Guiding Principles
    * Policy Positions
    * Access to Medicine
   
    * Government Submissions
    * Press Releases
   
    * Analysis & Reports
    * Letters

 * Resources
   
   RESOURCES
   
   IMC relies on trusted data and research to inform our work, and to create
   useful tools and resources for all stakeholders.
   
   Read more
   
    * All Resources
    * Analysis & Reports
    * Research
   
    * Infographics & Data
    * Private Drug Coverage
    * Related Links
   
    * Canadian Public Reimbursement Timelines
    * Pharma 101

 * Newsroom
   
   NEWSROOM
   
   Read the latest news from IMC, our members, and life science stakeholders.
   
   Read more
   
    * All News
    * Press Releases
   
    * In The News
    * Blog
   
    * Patient Stories

 * About
   
   ABOUT
   
   Learn more about IMC, our members, and our commitment to ethics and social
   responsibility.
   
   Read more
   
    * Our Industry
    * Vision & Mission
    * Our History
   
    * Board
    * Staff
    * Member Companies
   
    * Diversity, Equity & Inclusion
    * Ethics
    * Careers

 * Contact

 * 
 * 
 * 
 * 

 * Member Login

 *  * Français


 * * Browse by Topic
     * Private Drug Coverage
     * Health Research Foundation
     * Access to Medicine
     * Patented Medicine Prices Review Board (PMPRB)
     * Pharmacare
     * Drugs for Rare Diseases (DRD)




TRANSFORMING CANADIANS’ LIVES

Partnering to champion policies that drive the discovery, development and
delivery of transformative medicines and vaccines.

Read more

ACCESS TO MEDICINE

The Problem Two years is too long. Canadian patients wait two years for access
to approved new medicines through public […]

Read more

CAREERS

Want to make a difference in Canada’s healthcare system? We do too.

Read more

Press Release May 06, 2024

THE HEALTH RESEARCH FOUNDATION CALLS FOR NOMINATIONS FOR THE 2024 DIVERSITY &
EQUITY IN RESEARCH AWARD

Read more

Browse by topic



ACCESS TO MEDICINE

PATENTED MEDICINE PRICES REVIEW BOARD (PMPRB)

PHARMACARE

DRUGS FOR RARE DISEASES (DRD)

PRIVATE DRUG COVERAGE

HEALTH RESEARCH FOUNDATION

ACCESS TO MEDICINE

PATENTED MEDICINE PRICES REVIEW BOARD (PMPRB)

PHARMACARE

DRUGS FOR RARE DISEASES (DRD)

PRIVATE DRUG COVERAGE

HEALTH RESEARCH FOUNDATION

ACCESS TO MEDICINE

PATENTED MEDICINE PRICES REVIEW BOARD (PMPRB)

PHARMACARE

DRUGS FOR RARE DISEASES (DRD)

 * 1
 * 2
 * 3
 * 4
 * 5
 * 6






BENEFITS OF INNOVATIVE MEDICINES


REAL HOPE FOR PATIENTS AND FAMILIES

New medicines and vaccines save lives and help make our healthcare system more
cost‑effective.

Learn about IMC


TRANSFORMATION

Preventing or curing disease means extending lives, relieving suffering and
improving people’s quality of life.


SAFETY

Promoting a robust regulatory protocol means ensuring safe and effective
medicines for Canadians.


SUSTAINABILITY

Supporting sustainable healthcare means we all spend more time enjoying life and
being productive.


INDUSTRY IMPACT IN CANADA


BETTER HEALTH OUTCOMES


48

Innovative Medicines Canada members


107,000

High-quality jobs


$15.9 BILLION

Yearly economic impact


LATEST RESOURCES



Intellectual Property • April 16, 2024


IMC RESPONSE TO CONSULTATION ON SCIENTIFIC RESEARCH AND EXPERIMENTAL DEVELOPMENT

Learn more | View

Economic Impact • January 15, 2024


THE CANADIAN RESEARCH & DEVELOPMENT PHARMACEUTICAL SECTOR 2020

Learn more | View

Patented Medicine Prices Review Board (PMPRB) • January 04, 2024


IMC RESPONSE TO THE PMPRB’S 2023 SCOPING PAPER FOR THE CONSULTATIONS ON THE
BOARD’S GUIDELINES

Learn more | View

Access to Medicine • May 02, 2024


CLINICAL TRIALS RESEARCH NOTE

In many areas of high unmet patient need, early access to new medicines through
clinical trials are the only option for Canadian patients. There are over 3,000
ongoing clinical trials in Canada which provide significant value to patients.
Early access to innovative treatments improves health outcomes, increases
quality of life, and gives hope to patients and their loved ones. Clinical
trials also provide value to our healthcare system, research ecosystem, and
economy.

Learn more | View

Health Research Foundation • April 24, 2024


MEDAL OF HONOUR TERMS OF REFERENCE

Learn more | View

Health Research Foundation • April 24, 2024


MEDAL OF HONOUR NOMINATION FORM

Nominations for this year’s prestigious HRF Medal of Honour are now open. To
nominate an outstanding individual, complete the nomination form by July 15.
Submitted nominations will be considered for up to two award cycles. The
nominee’s work/research must have been performed in Canada by a Canadian
resident. To submit a nomination, please download and complete the form and send
to wdeen@imc-mnc.ca.

Learn more | View

Health Research Foundation • April 22, 2024


PRIX GALIEN CANADA – PRODUCT INNOVATION GUIDELINES

Please download and review the Prix Galien Canada – Product Innovation
Guidelines before submitting a nomination.

Learn more | View

Health Research Foundation • April 22, 2024


PRIX GALIEN CANADA – PRODUCT INNOVATION AWARD SUBMISSION FORM

The Prix Galien Canada – Innovative Product Award will be presented to a drug,
launched at least 12 months ago and no more than 60 months (5 years) ago, that
has made the most significant overall contribution to patient care in Canada,
according to the Jury of Prix Galien Canada.

Learn more | View

Intellectual Property • April 16, 2024


IMC RESPONSE TO CONSULTATION ON SCIENTIFIC RESEARCH AND EXPERIMENTAL DEVELOPMENT

Learn more | View

Economic Impact • January 15, 2024


THE CANADIAN RESEARCH & DEVELOPMENT PHARMACEUTICAL SECTOR 2020

Learn more | View

Patented Medicine Prices Review Board (PMPRB) • January 04, 2024


IMC RESPONSE TO THE PMPRB’S 2023 SCOPING PAPER FOR THE CONSULTATIONS ON THE
BOARD’S GUIDELINES

Learn more | View

Access to Medicine • May 02, 2024


CLINICAL TRIALS RESEARCH NOTE

In many areas of high unmet patient need, early access to new medicines through
clinical trials are the only option for Canadian patients. There are over 3,000
ongoing clinical trials in Canada which provide significant value to patients.
Early access to innovative treatments improves health outcomes, increases
quality of life, and gives hope to patients and their loved ones. Clinical
trials also provide value to our healthcare system, research ecosystem, and
economy.

Learn more | View

Health Research Foundation • April 24, 2024


MEDAL OF HONOUR TERMS OF REFERENCE

Learn more | View

Health Research Foundation • April 24, 2024


MEDAL OF HONOUR NOMINATION FORM

Nominations for this year’s prestigious HRF Medal of Honour are now open. To
nominate an outstanding individual, complete the nomination form by July 15.
Submitted nominations will be considered for up to two award cycles. The
nominee’s work/research must have been performed in Canada by a Canadian
resident. To submit a nomination, please download and complete the form and send
to wdeen@imc-mnc.ca.

Learn more | View

Health Research Foundation • April 22, 2024


PRIX GALIEN CANADA – PRODUCT INNOVATION GUIDELINES

Please download and review the Prix Galien Canada – Product Innovation
Guidelines before submitting a nomination.

Learn more | View

Health Research Foundation • April 22, 2024


PRIX GALIEN CANADA – PRODUCT INNOVATION AWARD SUBMISSION FORM

The Prix Galien Canada – Innovative Product Award will be presented to a drug,
launched at least 12 months ago and no more than 60 months (5 years) ago, that
has made the most significant overall contribution to patient care in Canada,
according to the Jury of Prix Galien Canada.

Learn more | View

Intellectual Property • April 16, 2024


IMC RESPONSE TO CONSULTATION ON SCIENTIFIC RESEARCH AND EXPERIMENTAL DEVELOPMENT

Learn more | View

Economic Impact • January 15, 2024


THE CANADIAN RESEARCH & DEVELOPMENT PHARMACEUTICAL SECTOR 2020

Learn more | View

Patented Medicine Prices Review Board (PMPRB) • January 04, 2024


IMC RESPONSE TO THE PMPRB’S 2023 SCOPING PAPER FOR THE CONSULTATIONS ON THE
BOARD’S GUIDELINES

Learn more | View

 * 1
 * 2
 * 3
 * 4
 * 5
 * 6
 * 7
 * 8

View all


LATEST PRESS RELEASES



Press Release February 23, 2024


WTO MINISTERIAL CONFERENCE IN ABU DHABI AN OPPORTUNITY TO STRENGTHEN TRADE AND
HEALTH AGENDA

23 FEBRUARY 2024, GENEVA – The meeting of global trade ministers at the World
Trade Organization’s 13th Ministerial Conference in […]

Press Release January 05, 2024


IMC STATEMENT ON THE FDA’S DECISION TO ALLOW FLORIDA TO IMPORT DRUGS FROM CANADA

Ottawa, January 5, 2024 – Innovative Medicines Canada (IMC) is deeply concerned
with the U.S. Food and Drug Administration’s (FDA) […]

Press Release December 04, 2023


INNOVATIVE PHARMACEUTICAL INDUSTRY STATEMENT ON COP28 DECLARATION ON CLIMATE AND
HEALTH

*This statement is available in English only. December 3, 2023, Geneva – The
innovative pharmaceutical industry commends the ambition to […]

Press Release May 06, 2024


THE HEALTH RESEARCH FOUNDATION CALLS FOR NOMINATIONS FOR THE 2024 DIVERSITY &
EQUITY IN RESEARCH AWARD

Nominate a researcher who has advanced diversity and equity in Canada by August
1,2024 Ottawa, May 6, 2024 – The […]

Press Release April 24, 2024


NOMINATIONS ARE NOW OPEN FOR THE 2024 HEALTH RESEARCH FOUNDATION’S MEDAL OF
HONOUR

Nominate outstanding contributions to health sciences, policy, and research by
July 15, 2024.

Press Release April 16, 2024


INNOVATIVE MEDICINES CANADA STATEMENT ON FEDERAL BUDGET 2024

Ottawa, April 16, 2024 – Innovative Medicines Canada (IMC) remains concerned
that the government’s proposed pharmacare model will not increase […]

Press Release March 19, 2024


INNOVATIVE MEDICINES CANADA WELCOMES BETTINA HAMELIN AS NEW PRESIDENT 

Ottawa, March 19, 2024 – Innovative Medicines Canada (IMC) is pleased to
announce Dr. Bettina Hamelin has been appointed as […]

Press Release February 29, 2024


INNOVATIVE MEDICINES CANADA STATEMENT ON PROPOSED PHARMACARE LEGISLATION

Ottawa, February 29, 2024 – Innovative Medicines Canada (IMC) is concerned with
the federal government’s intent in Bill C-64, An […]

Press Release February 23, 2024


WTO MINISTERIAL CONFERENCE IN ABU DHABI AN OPPORTUNITY TO STRENGTHEN TRADE AND
HEALTH AGENDA

23 FEBRUARY 2024, GENEVA – The meeting of global trade ministers at the World
Trade Organization’s 13th Ministerial Conference in […]

Press Release January 05, 2024


IMC STATEMENT ON THE FDA’S DECISION TO ALLOW FLORIDA TO IMPORT DRUGS FROM CANADA

Ottawa, January 5, 2024 – Innovative Medicines Canada (IMC) is deeply concerned
with the U.S. Food and Drug Administration’s (FDA) […]

Press Release December 04, 2023


INNOVATIVE PHARMACEUTICAL INDUSTRY STATEMENT ON COP28 DECLARATION ON CLIMATE AND
HEALTH

*This statement is available in English only. December 3, 2023, Geneva – The
innovative pharmaceutical industry commends the ambition to […]

Press Release May 06, 2024


THE HEALTH RESEARCH FOUNDATION CALLS FOR NOMINATIONS FOR THE 2024 DIVERSITY &
EQUITY IN RESEARCH AWARD

Nominate a researcher who has advanced diversity and equity in Canada by August
1,2024 Ottawa, May 6, 2024 – The […]

Press Release April 24, 2024


NOMINATIONS ARE NOW OPEN FOR THE 2024 HEALTH RESEARCH FOUNDATION’S MEDAL OF
HONOUR

Nominate outstanding contributions to health sciences, policy, and research by
July 15, 2024.

Press Release April 16, 2024


INNOVATIVE MEDICINES CANADA STATEMENT ON FEDERAL BUDGET 2024

Ottawa, April 16, 2024 – Innovative Medicines Canada (IMC) remains concerned
that the government’s proposed pharmacare model will not increase […]

Press Release March 19, 2024


INNOVATIVE MEDICINES CANADA WELCOMES BETTINA HAMELIN AS NEW PRESIDENT 

Ottawa, March 19, 2024 – Innovative Medicines Canada (IMC) is pleased to
announce Dr. Bettina Hamelin has been appointed as […]

Press Release February 29, 2024


INNOVATIVE MEDICINES CANADA STATEMENT ON PROPOSED PHARMACARE LEGISLATION

Ottawa, February 29, 2024 – Innovative Medicines Canada (IMC) is concerned with
the federal government’s intent in Bill C-64, An […]

Press Release February 23, 2024


WTO MINISTERIAL CONFERENCE IN ABU DHABI AN OPPORTUNITY TO STRENGTHEN TRADE AND
HEALTH AGENDA

23 FEBRUARY 2024, GENEVA – The meeting of global trade ministers at the World
Trade Organization’s 13th Ministerial Conference in […]

Press Release January 05, 2024


IMC STATEMENT ON THE FDA’S DECISION TO ALLOW FLORIDA TO IMPORT DRUGS FROM CANADA

Ottawa, January 5, 2024 – Innovative Medicines Canada (IMC) is deeply concerned
with the U.S. Food and Drug Administration’s (FDA) […]

Press Release December 04, 2023


INNOVATIVE PHARMACEUTICAL INDUSTRY STATEMENT ON COP28 DECLARATION ON CLIMATE AND
HEALTH

*This statement is available in English only. December 3, 2023, Geneva – The
innovative pharmaceutical industry commends the ambition to […]

 * 1
 * 2
 * 3
 * 4
 * 5
 * 6
 * 7
 * 8

View all


RESOURCES


DISCOVER. LEARN.
UNDERSTAND.

Informative content to keep you up to date on the most pressing issues facing
our industry.

Learn More

 * Advocacy
 * Resources
 * Newsroom

 * About
 * Contact
 * Français

 * Health Research Foundation
 * Terms and Conditions
 * Privacy Policy
 * Competition Guidelines
 * Accessible Service Plan
 * Competition Guidelines Regarding Meetings

©2024 Innovative Medicines Canada. All Rights Reserved.  Design by baytek

Member of